Vorinostat Active Not Recruiting Phase 1 Trials for Advanced Cancers Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01266057Sirolimus or Vorinostat and Hydroxychloroquine in Advanced Cancer
NCT02042989MLN9708 and Vorinostat in Patients With Advanced p53 Mutant Malignancies